BPC-157
Research Use Only | Not for Human Consumption
A 15-amino-acid peptide originally isolated from gastric juice; used in preclinical research since the early 1990s.
BPC-157 is a short chain of amino acids, a peptide originally isolated from gastric juice. It has been studied in preclinical models for effects on tissue regeneration pathways and inflammatory signaling cascades.
| CAS# | Formula | Molar Mass |
|---|---|---|
| 137525-51-0 | C₆₂H₉₈N₁₆O₂₂ | 1419.55 g/mol |
All products are shipped in lyophilized form and must be reconstituted for in-vitro research applications. Refer to the Certificate of Analysis for purity and identity specifications.
A 15-amino-acid peptide originally isolated from gastric juice
What is BPC-157?
BPC-157, short for "Body Protection Compound-157," was first identified during research on human gastric juice in the early 1990s. Croatian researchers at the University of Zagreb, led by Dr. Predrag Sikirić, originally isolated this sequence from a larger protective protein found naturally in the stomach—which is where the "Body Protection Compound" name originated.
Over the past three decades, BPC-157 has become one of the more extensively studied peptides in preclinical research. Hundreds of peer-reviewed publications have examined its interactions with various biological systems, including nitric oxide pathways, growth factor signaling, and angiogenic processes.
Research interest has spanned multiple biological systems—from gastrointestinal and musculoskeletal models to neurological and vascular studies. While preclinical data has accumulated over 30+ years, it's worth noting that human clinical trials remain limited, and most published findings come from animal or in vitro studies.
What is BPC-157 studied for?
The following research areas represent documented studies available in the scientific literature. We make no claims regarding the benefits, efficacy, or therapeutic applications of this product.
Tissue Regeneration Research
Investigated in preclinical models for its effects on muscle, tendon, and ligament tissue repair mechanisms
Wound Healing Research
Examined in animal wound models for observations related to tissue closure and ulcer repair pathways
Anti-inflammatory Research
Studied in laboratory research for interactions with inflammation-related signaling pathways across various tissue types
Gastrointestinal Research
Evaluated in preclinical GI tissue models for observations related to gastric and intestinal mucosal integrity
Nociceptive Research
Investigated in animal studies examining nociceptive pathways and pain-related behavioral models
Nerve Tissue Research
Studied in preclinical models examining nerve tissue regeneration and neuronal repair mechanisms
How should BPC-157 be stored?
All of our products are manufactured using the Lyophilization (Freeze Drying) process, which ensures that our products remain 100% stable for shipping for up to 3-4 months.
Once the peptides are reconstituted (mixed with bacteriostatic water), they must be stored in the fridge to maintain stability.
After reconstitution, the peptides will remain stable for up to 30 days.
Certificate of Analysis
All BPC-157 batches are independently tested by a third-party laboratory for purity and identity verification via HPLC with UV detection coupled with Mass Spectrometry.
HPLC Purity
—
No Certificate of Analysis is available for the selected size yet. Contact support for batch-specific documentation.
COA documents are updated with each new batch. Contact support for batch-specific documentation.
Related Research Compounds
Frequently purchased with BPC-157
Add all 3 items to your cart
$335
Clinical References
- Chang CH, et al. Pentadecapeptide BPC 157 enhances the growth hormone receptor expression in tendon fibroblasts. Molecules. 2014. PubMed: 25415472
- Staresinic M, et al. BPC 157 accelerates healing of transected rat Achilles tendon and in vitro stimulates tendocyte growth and VEGF secretion. Journal of Orthopaedic Research. 2003. PubMed: 14554208
- Sikiric P, et al. Stable gastric pentadecapeptide BPC 157: novel therapy in gastrointestinal tract. Current Pharmaceutical Design. 2011. PubMed: 21548867
- Sikiric P. The effect of pentadecapeptide BPC 157 on gastrointestinal tract. Journal of Physiology and Pharmacology. 2013. PubMed: 24304574
